These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3783175)

  • 1. Carbamazepine-viloxazine interaction in patients with epilepsy.
    Pisani F; Fazio A; Oteri G; Perucca E; Russo M; Trio R; Pisani B; Di Perri R
    J Neurol Neurosurg Psychiatry; 1986 Oct; 49(10):1142-5. PubMed ID: 3783175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of viloxazine on serum carbamazepine levels in epileptic patients.
    Pisani F; Narbone MC; Fazio A; Crisafulli P; Primerano G; D'Agostino AA; Oteri G; Di Perri R
    Epilepsia; 1984 Aug; 25(4):482-5. PubMed ID: 6745218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of plasma phenytoin by viloxazine in epileptic patients: a clinically significant drug interaction.
    Pisani F; Fazio A; Artesi C; Russo M; Trio R; Oteri G; Perucca E; Di Perri R
    J Neurol Neurosurg Psychiatry; 1992 Feb; 55(2):126-7. PubMed ID: 1538217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy.
    Pisani F; Fazio A; Oteri G; Artesi C; Xiao B; Perucca E; Di Perri R
    Acta Neurol Scand; 1994 Aug; 90(2):130-2. PubMed ID: 7801739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of valpromide and viloxazine on the elimination of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.
    Perucca E; Pisani F; Spina E; Oteri G; Fazio A; Bertilsson L
    Pharmacol Res; 1989; 21(1):111-2. PubMed ID: 2498859
    [No Abstract]   [Full Text] [Related]  

  • 6. Viloxazine plasma concentrations and clinical response.
    Norman TR; Burrows GD; Davies BM; Maguire KP; Wurm JM
    J Affect Disord; 1980 Sep; 2(3):157-64. PubMed ID: 6210721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epoxide of carbamazepine.
    McKauge L; Tyrer JH; Eadie MJ
    Clin Exp Neurol; 1979; 16():95-104. PubMed ID: 550961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viloxazine and the depressed schizophrenic--methodological issues.
    Kurland AA; Nagaraju A
    J Clin Pharmacol; 1981 Jan; 21(1):37-41. PubMed ID: 7012190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does viloxazine have epileptogenic properties?
    Edwards JG; Glen-Bott M
    J Neurol Neurosurg Psychiatry; 1984 Sep; 47(9):960-4. PubMed ID: 6434699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy of melancholia by sequential neuroleptic-viloxazine association].
    Brion S; Chevalier JF; Guerin R; Ginestet D
    Encephale; 1976; 2(3):257-71. PubMed ID: 991806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical and pharmacological study of the antidepressant activity of viloxazine in adult and elderly patients.
    Tosca P; Zerbi F; Romani A; Molini G; Cairoli S; Montagna M; Gabba A; Groppi A
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):270-3. PubMed ID: 4008117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of the antidepressant drug viloxazine in normal subjects and in epileptic patients receiving chronic anticonvulsant treatment.
    Pisani F; Fazio A; Spina E; Artesi C; Pisani B; Russo M; Trio R; Perucca E
    Psychopharmacology (Berl); 1986; 90(3):295-8. PubMed ID: 3097715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbamazepine-10,11-epoxide in epilepsy. A pilot study.
    Tomson T; Almkvist O; Nilsson BY; Svensson JO; Bertilsson L
    Arch Neurol; 1990 Aug; 47(8):888-92. PubMed ID: 2375696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response.
    Post RM; Uhde TW; Ballenger JC; Chatterji DC; Greene RF; Bunney WE
    Arch Gen Psychiatry; 1983 Jun; 40(6):673-6. PubMed ID: 6847334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theophylline toxicity following coadministration of viloxazine.
    Thomson AH; Addis GJ; McGovern EM; McDonald NJ
    Ther Drug Monit; 1988; 10(3):359-60. PubMed ID: 3176117
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of disulfiram on the serum concentration of carbamazepine in patients with epilepsy.
    Krag B; Dam M; Angelo H; Christensen JM
    Acta Neurol Scand; 1981 Jun; 63(6):395-8. PubMed ID: 7324869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic interaction of brivaracetam on carbamazepine in adult patients with epilepsy, with and without valproate co-administration.
    Stockis A; Sargentini-Maier ML; Brodie MJ
    Epilepsy Res; 2016 Dec; 128():163-168. PubMed ID: 27842261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age, therapeutic "milieu" and clinical outcome in depressive patients treated with viloxazine: a study with plasma levels.
    Altamura AC; Mauri MC; Guercetti G
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(1):67-75. PubMed ID: 3704174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined treatment with nialamide and viloxazine in depressed patients (author's transl)].
    Kabes J
    Cesk Psychiatr; 1979 Jun; 75(3):166-74. PubMed ID: 527077
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide. An update.
    Bertilsson L; Tomson T
    Clin Pharmacokinet; 1986; 11(3):177-98. PubMed ID: 3524954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.